Shanghai Haohai Biological Technology : CHANGE OF VENUE OF EXTRAORDINARY GENERAL MEETING, A SHAREHOLDERS' CLASS MEETING AND H SHAREHOLDERS' CLASS MEETING TO BE HELD ON FEBRUARY 14, 2020

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Shanghai Haohai Biological Technology Co., Ltd.*

上海昊海生物科技股份有限公司

(a joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 6826)

CHANGE OF VENUE OF EXTRAORDINARY GENERAL MEETING,

1. SHAREHOLDERS' CLASS MEETING AND H SHAREHOLDERS' CLASS MEETING TO BE HELD ON FEBRUARY 14, 2020

References are made to (1) the notice of 2020 first extraordinary general meeting (the "EGM") of Shanghai Haohai Biological Technology Co., Ltd.* (the "Company") dated December 30, 2019; (2) and the notice of 2020 first H shareholders' class meeting of the Company (the "H Shareholders' Class Meeting") dated December 30, 2019; and (3) the circular of the Company dated January 21, 2020 (the "Circular"). Unless otherwise defined herein, capitalized terms used in this announcement shall have the same meanings as those defined in the Circular.

The board of directors of the Company (the "Board") announces that, due to the recent outbreak of the Novel Coronavirus and after due consideration, the venue of the EGM, the 2020 first A shareholders' class meeting of the Company (the "A Shareholders' Class Meeting") and the H Shareholders' Class Meeting (collectively referred to as the "Meetings") to be held on Friday, February 14, 2020 by the Company will be changed to 24/F, WenGuang Plaza, No. 1386 Hongqiao Road, Changning District, Shanghai, PRC.

Save for the aforesaid change, all the information and contents set forth in the notices of the Meetings and the Circular remain unchanged. The forms of proxy attached to the notices of the Meetings remain valid. Shareholders of the Company (the "Shareholders") who intend to attend the Meetings are advised to pay attention to the change of the meeting venue as stated above. The Board apologizes for any inconvenience that may be caused to the Shareholders and investors, and would like to express its gratitude to the Shareholders and investors for your support and understanding.

By order of the Board

Shanghai Haohai Biological Technology Co., Ltd.*

Chairman

Hou Yongtai

Shanghai, the PRC, February 10, 2020

As at the date of this announcement, the executive directors of the Company are Dr. Hou Yongtai, Mr. Wu Jianying, Ms. Chen Yiyi and Mr. Tang Minjie; the non-executive directors of the Company are Ms. You Jie and Mr. Huang Ming; and the independent non-executive directors of the Company are Mr. Chen Huabin, Mr. Shen Hongbo, Mr. Zhu Qin and Mr. Wong Kwan Kit.

• For identification purpose only